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1. Introduction 
Diphtheria toxin kills cells by inhibiting protein 
synthesis through the ADP-ribosylation of protein 
synthesis elongation factor 2 (EF-2) [ 1,2]. In this 
reaction, the catalytically active fragment of the toxin, 
fragment A, exibits exceedingly narrow specificity. 
The only known substrate for the enzyme under the 
usual reaction conditions is EF-2. Not only is EF-2 
the only substrate in toxin-sensitive cells but appar- 
ently toxin will ADP-ribosylate EF-2 from all 
eukaryotic sources. 
We have found [4-61 that all cases the ADP-ribose 
is attached by diphtheria toxin to EF-2 via an unusual 
ammo acid, diphthamide, which is not known to occur 
in other proteins. Diphthamide appears to be an 
unusual derivative of histidine for which we have 
proposed the structure 2-[3-carboxyamide-3-(tri- 
methylammonio)propyl] histidine [3]. These findings 
raise the possibility that toxin recognizes EF-2 simply 
by the presence of this unusual amino acid derivative. 
In the course of examining the interaction of toxin 
with EF-2 we have observed that toxin does not ADP- 
ribosylate the trypsinderived peptide which contains 
diphthamide. Hence it would appear that toxin recog- 
nizes some additional feature(s) of EF-2 besides the 
presence of diphthamide in peptide bond. We report 
these findings here. 
2. Materials and methods 
[adenylate-32P]NAD’ and [adenir~e-2,8-~H]NAD+ 
were purchased from New England Nuclear Corp. 
* Present Address: Institute for Cancer Research, Fox Chase, 
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Yeast EF-2 was prepared (-10% pure) as in [6] and 
in some cases was further purified (-40% pure) by 
chromatography on DEAE-cellulose and Sephadex 
G-150. The trypsinderived [32P]ADP-ribosyl peptide 
was also prepared as in [4]. Published methods were 
used for the toxin-dependent ADP-ribosylation, tryp- 
sin digestion reactions [4] and for sodium dodecyl- 
sulfate (SDS)-polyacrylamide gel electrophoresis [7]. 
3. Results 
EF-2 from various sources is a single peptide chain 
ofM, -100 000 [2]. In rat liver extracts the protein 
can be acted upon by endogenous proteases to signif- 
icantly reduce the size of the ADP-ribose acceptor 
when analyzed in denaturing systems [8]. We have 
observed similar results with the yeast protein but in 
no case did we observe fragments smaller than 
-25 000 Mr Fig.1 shows an autoradiogram of an SDS 
gel of yeast EF-2 which was [32P]ADP-ribosylated 
before and after various times of treatment with tryp- 
sin. Under these conditions the intact chain was 
rapidly cleaved so that the major [32P]ADP-ribose 
acceptor exhibited - 25 000-35 000 MT Prolonged 
treatment did not produce smaller labeled fragments. 
The experiment shown in fig.2 examines the effects 
of trypsin digestion on the amount of ADP-ribosyla- 
tion of EF-2 by toxin. The open symbols describe the 
results of experiments in which [ 3H] ADP-ribosyl- 
EF-2 formation was determined as a function of the 
time of treatment with two concentrations of trypsin 
(trypsin:protein ratios of 1:50 and 1: 1, respectively). 
Most of the radioactive material remained insoluble in 
acid with both trypsin levels. 
In contrast, the closed symbols show that very little 
acid-insoluble material was observed when EF-2 was 
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Fig.1. Autoradiogram of an SDS gel of EF-2 which was [“PI. 
ADP-ribosylated with diphtheria toxin after various periods 
of digestion with trypsin. EF-2 was digested with trypsin 
(trypsin:protein ratio, 1:lOO) for theindicated times at 37°C. 
The digestion was terminated by the addition of soybean 
trypsin inhibitor (1 mg/ml). The protein was then ]32P]ADP- 
ribosylated with diphtheria toxin and ]3*P]NAD’ [4] and 
subjected to SDS slab-gel ele~rophoresis 191 and autoradiog- 
raphy. The mobilities of standard proteins and their molecular 
weights are indicated to the left. 
treated with trypsin (1:SO) prior to [ 3H] ADP-ribosyl- 
ation with toxin. These latter results indicate that 
either the [3H]ADP-ribose is attached to an acid- 
soluble fragment of EF-2 or that trypsin cleavage has 
altered the protein so that it is not reco~ized by the 
toxin. 
We have observed that the ADP-ribosyl peptide 
obtained by complete digestion of EF-2 by trypsin 
is acid-soluble (not shown). Therefore, to distinguish 
between the two possibilities raised above we employ. 
ed gel permeation chromatography to determine if 
the tryptic peptide which contains diphthamide is a 
substrate for diphtheria toxin. A preparation of par- 
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Fig.2. The effect of trypsin digestion of EF-2 before and 
after its ADP-ribosylation by toxin. In one case [ 3H JADP- 
ribosyl EF-2 was digested for the indicated times at 37°C 
with either 1:50 trypsin (A) or 1 :l trypsin (0) and the reac- 
tions were precipitated with 10% trichloroacetic acid and 
counted. In comparison EF-2 (0) was first digested with tryp 
sin (1:SO) and the reaction was stopped with soybean trypsin 
inhibitor (1 mg/ml). Diphtheria toxin and [ 3H] NAD+ were 
added and after 15 mm incubation at 37°C the samples were 
precipitated with 10% ~i~hloroa~tic acid and counted. In 
each case the results are expressedas the percent of radio- 
activity precipitated when trypsin inhrbitor was added prior 
to trypsin. 
tially purified EF-2 was divided in half. One half was 
[3H]ADP-ribosylated, digested with trypsin under 
denaturing conditions which lead to complete pro- 
teolytic cleavage [4], and the resulting peptides were 
chromatographed on Sephadex G-l 5 (fig.3). The 
radioactive ADP-ribosyl-peptide was observed in the 
column void volume (open symbols). In contrast, 
the remaining portion of the EF-2 preparation was 
first degraded with trypsin and the peptides were 
reacted with toxin and [3H]NAD+. The closed sym- 
bols in fig.3 show that under these circumstances all 
of the radioactivity was recovered as [3H] NAD’ and 
none as the ~3H]ADP-ribosyl peptide. Emplo~ng the 
rat liver protein Maxwell (personal commu~cation) 
has also observed that the trypsinderived peptide is 
not ADP-ribosylated by toxin. 
Further evidence that the trypsin-derived peptide 
is not a substrate for toxin was provided by the revers- 
ibility of the toxin reaction [ 1,2]. The E3H] ADP- 
ribosyl peptide was reacted with toxin and nicotin- 
amide at acid pH, conditions which favor the reverse 
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Fig.3. Gel permeation analysis of the [sH]ADP-ribosyl pep- 
tide. In the experiment represented by the open circles, 
50 ml of an EF-2 preparation (3.2 mg/ml) was [ 3H] ADP- 
ribosylated with [ ‘H]NAD+ (10 #M, 1 Ci/mmol) and toxin 
(30 min at 2O’C) and the protein was precipitated with 10% 
trichloroacetic acid and washed. The precipitate was dissolved 
in 50 ml buffer and digested at 37°C with two additions of 
trypsin (1 :lOO) followed by 5 mg soybean trypsin inhibitor. 
Ten ml of this solution was applied to a 2.6 X 53 cm column 
of Sephadex G-15 equilibrated and eluted with 20 mM 
ammonium acetate @H 8.0). Fractions were collected and 
aliquots were counted. In the experiment represented by the 
closed circles, 50 ml of the same EF-2 preparation was fist 
precipitated with 10% trichloroacetic acid and the precipitate 
was washed and dissolved in 50 ml buffer. The protein was 
digested with trypsin and the reaction was terminated with 
trypsin inhibitor as above. Diphtheria toxin and [3H]NAD’, 
in the levels used above, were then added and the solution 
was incubated as described. Ten ml of this solution was 
applied to the same Sephadex G-15 column and aliquots of 
the eluting fractions were counted. The V. and VT designa- 
tions in the figure represent he column void and total 
volumes, respectively- 
reaction. Upon analysis by thin-layer chromatography, 
al1 of the radioactivity was recovered in the original 
peptide and none as [3H]NAD+ (not shown). Under 
comparable conditions using the intact protein the 
reaction was 50-90% reversible. 
4. Discussion 
Diphthamide, occurs within a highly conserved 
sequence in apparently all EF-2 s [5]. The amino acid 
in this protein is the only known substrate for diph- 
theria toxin and it is reasonable to conclude that its 
presence plays an important part in recognition of the 
protein by the toxin. Indeed, the results in f9] suggest 
that complete post-translational modification or the 
presumed histidine progenitor of diphthamide is
required for toxin recognition. 
These results indicate that EF-2 can sustain only a 
limited number of proteolytic cleavages before it is 
no longer recognized by diphtheria toxin, Moreover, 
the toxin appears to be completely inactive in either 
the forward or back reaction with the tryptic peptide 
which contains diphthamide. It thus appears that 
diphtheria toxin recognizes something in EF-2 beyond 
the presence of diphthamide. These findings uggest 
the possibility that diphthamide may occur in other 
proteins which are not substrates for diphtheria toxin. 
We thank Sharon Bloom for performing some of 
the experiments described here. This work was sup- 
ported by grant GM-26832 from the National Insti- 
tutes of Health. 
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